Europe Mammography Market

Europe Mammography Market Size (2023 to 2028)

The size of the mammography market in Europe was valued at USD 484.86 million in 2023. This value is expected to reach USD 641.84 million by the end of 2028, with a CAGR of 5.77% during the forecast period.

The rising prevalence of breast cancer among women is driving the mammography market growth. Mammography is an X-ray imaging method that is used for detecting breast cancer at an early stage. Breast cancer is the most common type of cancer faced by the European population. According to a report of the Joint Research Commission of the European Commission in 2021, breast cancer is the most common type of cancer in Europe reporting; that more than 355,000 women in the European Union were diagnosed with breast cancer in 2021, which is 13.4% among all cancer diagnosis. The rising cases of breast cancer are demanding better diagnosis techniques, which is increasing the mammography market expansion across the European region the rising technological advancements in the diagnosis procedures which is increasing the screening methods. The improvements in breast cancer imaging technology are raising the cases of early detection of breast cancer. 

The increasing government initiatives for bringing awareness of breast cancer among the people are boosting the growth of market value. According to an article published in October 2021, “Breast Cancer Affects Us All” is the breast cancer awareness campaign created by Wefra Life and the non-profit association Pink Ribbon Germany in collaboration with the government. These initiatives and actions by the government are expected to raise the demand for mammography techniques among the people by raising the market revenue. 

Several health professionals and organizations are raising awareness of breast cancer, which is influencing people to take diagnostic tests for positive cases, which is expected to create growth opportunities for the mammography market in Europe. The government guidelines and regulations for mammography screening are gaining trust among the European population, creating possibilities for market expansion. The rising advancements in technological procedures are making diagnosis simple by emitting rapid results, which is expected to augment the market

Exposure to ionizing radiation is the primary factor hampering the mammography market expansion. Mammography has shown false positives in some cases where overdiagnosis is also noted. Sensitivity is high in the mammography procedure where some cases noted the radiation injury. All these factors are hindering the adoption of mammography procedures, impacting the market revenue.

The major restraining factor for mammography is in the case of certain types of breasts; the interpretation is difficult due to the variation in breast tissue density. In some specific cases, only mammography is not enough for the diagnosis, which demands other procedures such as MRI to raise the accuracy of the exam. In most cases, mammography detects the mass in breasts, which does not require any treatment as they can be clinically solved. These factors are estimated to be challenging for market expansion across the European region.

This research report segmented and sub-segmented the Europe mammography market into the following categories:

By Product:

• 3D Mammograms
• Digital
• Analog System
• Film Screens
• Biopsy Systems
• Others

The digital mammography segment dominated the European market in 2022 with the largest market share. Digital mammography is an advanced form of screening that is helpful in the detection of breast disease. Incorporating the advanced technology in the digital segment is expected to drive the market growth. Digital mammography, in collaboration with the computer manipulation of images, leads to further techniques such as tomosynthesis, which is expected to create market growth opportunities in the digital segment over the forecast period. 

By Technology:

• Analog
• Digital
• Breast tomosynthesis

The digital technology segment held the largest share of the European mammography market in 2022 and is expected to dominate during the forecast period. The increasing adoption of digital transformation across the European region is influencing people to seek digital solutions for diagnosis and treatment. 

By Application:

• Screening
• Diagnostics

The screening segment dominated the European mammography market 2022 with the most significant share. Most of the health professionals and organizations are educating people regarding the importance of screening to avoid the risk of cancer. Women are showing interest in screening techniques for preventive measures. Rising health awareness among the people is influencing them to take preventive measures and regular checkups, which is increasing market revenue in the screening segment. 

By Country: 

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

The UK dominated the European mammography market due to increasing cases of breast cancer. According to 2022 statistics, about 56,000 women are diagnosed with breast cancer every year, which is about 150 cases per day in the United Kingdom. According to the same source, breast cancer cases have increased by 24% over the last 23 years in Europe and 5% over 10 years in the United Kingdom. The increasing investments by the market players in research and development activities and the rising awareness programs by the organizations are increasing the market revenue of mammography in the UK. Germany held the second position in the regional market revenue due to the rising initiatives by the government to spread information regarding breast cancer to women. France and Spain are expected to have steady market growth over the forecast period due to increasing screening mammography tests across the region. Growing advancements in technology adopted by the European healthcare system drive market growth. 

KEY MARKET PLAYERS:

Companies playing a promising role in the Europe mammography market profiled in this report are Fujifilm, GE Healthcare, Hologic, Metaltronica, Philips Healthcare, Planmed, Siemens Healthcare, Sonocine, and Toshiba Medical Systems.